论文部分内容阅读
目的:探讨通心络胶囊治疗2型糖尿病合并冠心病心绞痛患者的临床疗效。方法:选取我院2013年10月至2014年8月接收的2型糖尿病合并冠心病心绞痛患者46例,随机将其分成对照组和观察组两组,对对照组患者进行常规降糖和抗心绞痛治疗;对观察组患者则在对照组基础上加用通心络胶囊进行治疗,之后观察并对比两组疗效。结果:观察组的空腹血糖值及心绞痛发作次数和持续时间均明显低于对照组,总有效率明显高于对照组,两者差异明显具有统计学意义(P<0.05)。结论:对2型糖尿病合并冠心病心绞痛患者采用通心络胶囊进行治疗,可有效提高患者的治疗效果,值得临床推广和应用。
Objective: To investigate the clinical effect of Tongxinluo capsule on type 2 diabetes mellitus patients with coronary heart disease and angina pectoris. Methods: Forty-six patients with type 2 diabetes mellitus and coronary heart disease angina pectoris received in our hospital from October 2013 to August 2014 were randomly divided into control group and observation group. The patients in control group were given routine hypoglycemic and anti-angina The patients in the observation group were treated with Tongxinluo capsule on the basis of the control group, after which the curative effect was observed and compared between the two groups. Results: The fasting blood glucose and angina pectoris frequency and duration in the observation group were significantly lower than those in the control group, and the total effective rate was significantly higher than that in the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion: The treatment of type 2 diabetes mellitus with angina pectoris patients with Tongxinluo capsule can effectively improve the therapeutic effect of patients, worthy of clinical promotion and application.